Applied DNA Sciences Stock (NASDAQ:APDN)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.34

52W Range

$0.31 - $23.60

50D Avg

$1.07

200D Avg

$5.48

Market Cap

$3.81M

Avg Vol (3M)

$10.34M

Beta

0.33

Div Yield

-

APDN Company Profile


Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

52

IPO Date

Jul 15, 2003

Website

APDN Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 23Sep 22Sep 21
Research and Development Services (Over-Time)$421.58K--
Supply Chain$827.60K--
Asset Marking$311.81K--
Clinical Laboratory Testing Services (Over-Time)$3.54M--
Clinical Laboratory Testing Services (Point-in-Time)$7.61M--
Large Scale DNA Production$653.01K--
Supply chain-$887.06K$1.00M
Asset marking-$534.59K$458.41K
Clinical laboratory testing services (over-time)-$5.13M-
Clinical laboratory testing services (point-in-time)-$10.40M$4.79M
Research and development services (over-time)-$592.00K$799.72K
Diagnostic kits--$1.97M

Fiscal year ends in Sep 23 | Currency in USD

APDN Financial Summary


Sep 23Sep 22Sep 21
Revenue$13.37M$18.17M$9.03M
Operating Income$-10.95M$-13.97M$-12.29M
Net Income$-9.95M$-8.38M$-16.03M
EBITDA$-10.45M$-21.38M$-9.69M
Basic EPS$-0.76$-0.93$-2.32
Diluted EPS$-0.76$-0.93$-2.32

Fiscal year ends in Sep 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Aug 11, 24 | 12:29 PM
Q1 24Feb 09, 24 | 1:32 PM
Q4 23Dec 08, 23 | 3:13 PM

Peer Comparison


TickerCompany
GTHGenetron Holdings Limited
PSNLPersonalis, Inc.
OCXOncoCyte Corporation
XGNExagen Inc.
SERASera Prognostics, Inc.
BNRBurning Rock Biotech Limited
ISPCiSpecimen Inc.
PREPrenetics Global Limited
DRIODarioHealth Corp.
OLKOlink Holding AB (publ)
BDSXBiodesix, Inc.
MYNZMainz Biomed B.V.
FONRFONAR Corporation
STIMNeuronetics, Inc.
TRIBTrinity Biotech plc